Pharmaceutical company Merck says that it will stop using chimpanzees in its biomedical research efforts, according to the Wall Street Journal. The company says newer technologies and alternate approaches can replace the use of chimpanzees in drug research.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Chimps' Retirement

This Week in Science

This Week in Science

Changes to Gut Bugs

Academic Image

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.